Michael Clifton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Michael Clifton has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Kiyon Naser-Tavakolian
Division of Interventional Radiology, Department of Radiology, Columbia University Irving Medical Center, New York, NY 10032, USA
2 shared publications - Abin Sajan
Division of Interventional Radiology, Department of Radiology, Columbia University Irving Medical Center, New York, NY 10032, USA
1 shared publication - Ahmed Abdelal
Guerbet, Princeton, NJ 08540, USA
1 shared publication - Alyssa Knight
Vascular and Interventional Radiology, University of Alabama Birmingham, Birmingham, AL 35294, USA
1 shared publication - Ana M. Franceschi
Department of Radiology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Health, Manhasset, NY
1 shared publication - Ana Marija Franceschi
Department of Radiology, Neuroradiology Division, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Lenox Hill Hospital, New York, NY
1 shared publication
Latest Publications
- Open Access
Thermal Ablation of Hypervascular Liver Tumors After Selective Intra-Arterial Lipiodol Injection (SIALI): A Technical Narrative Review of Technique, Institutional Variations, and Published Evidence
Purpose: Percutaneous thermal ablation of hypervascular liver tumors is limited by lesion conspicuity on conventional imaging, challenges with ablative margin assessment, and unequal global access to advanced technologies such as ablation confirmation software and radioembolization. This review describes the selective intra-arterial lipiodol injection (SIALI) technique, its technical variations across institutions, and summarizes published clinical outcomes for SIALI-guided thermal ablation of hepatic malignancies. Methods: A narrative review was conducted through structured searches of the PubMed, Embase, and Cochrane databases using terms including “selective intra-arterial lipiodol injection,” “lipiodol-guided ablation,” “SIALI,” and “hepatic arterial lipiodol.” Studies were selected based on relevance to SIALI technique, clinical outcomes, and comparator techniques, including hepatic arteriography with C-arm CT-guided ablation (hepACAGA) and ablation confirmation software. Full-text peer-reviewed articles were included; conference abstracts and letters were excluded. No formal PRISMA-compliant inclusion or exclusion criteria were applied, consistent with the narrative review format. Results: Seven studies were identified, encompassing six retrospective cohort studies and one prospective randomized controlled trial, collectively comprising over 900 patients treated across institutions in Asia, Europe, and the United States. Across heterogeneous patient populations and technical approaches, SIALI-guided thermal ablation was associated with improved local tumor recurrence rates, local recurrence-free survival, and overall survival compared with conventional ultrasound- or CT-guided ablation alone in selected studies where comparator data were available, with favorable technical success rates in lesions otherwise occult on standard imaging. Conclusion: SIALI appears to be a technically feasible and potentially useful adjunct technique that may improve lesion conspicuity and enable real-time ablative margin assessment in the treatment of hypervascular liver tumors, particularly in settings without access to ablation confirmation software. The available evidence is predominantly retrospective, and prospective validation is needed before broad conclusions regarding oncologic outcomes can be drawn.
Open AccessThermal Ablation of Hypervascular Liver Tumors After Selective Intra-Arterial Lipiodol Injection (SIALI): A Technical Narrative Review of Technique, Institutional Variations, and Published Evidence
Purpose: Percutaneous thermal ablation of hypervascular liver tumors is limited by lesion conspicuity on conventional imaging, challenges with ablative margin assessment, and unequal global access to advanced technologies such as ablation confirmation software and radioembolization. This review describes the selective intra-arterial lipiodol injection (SIALI) technique, its technical variations across institutions, and summarizes published clinical outcomes for SIALI-guided thermal ablation of hepatic malignancies. Methods: A narrative review was conducted through structured searches of the PubMed, Embase, and Cochrane databases using terms including “selective intra-arterial lipiodol injection,” “lipiodol-guided ablation,” “SIALI,” and “hepatic arterial lipiodol.” Studies were selected based on relevance to SIALI technique, clinical outcomes, and comparator techniques, including hepatic arteriography with C-arm CT-guided ablation (hepACAGA) and ablation confirmation software. Full-text peer-reviewed articles were included; conference abstracts and letters were excluded. No formal PRISMA-compliant inclusion or exclusion criteria were applied, consistent with the narrative review format. Results: Seven studies were identified, encompassing six retrospective cohort studies and one prospective randomized controlled trial, collectively comprising over 900 patients treated across institutions in Asia, Europe, and the United States. Across heterogeneous patient populations and technical approaches, SIALI-guided thermal ablation was associated with improved local tumor recurrence rates, local recurrence-free survival, and overall survival compared with conventional ultrasound- or CT-guided ablation alone in selected studies where comparator data were available, with favorable technical success rates in lesions otherwise occult on standard imaging. Conclusion: SIALI appears to be a technically feasible and potentially useful adjunct technique that may improve lesion conspicuity and enable real-time ablative margin assessment in the treatment of hypervascular liver tumors, particularly in settings without access to ablation confirmation software. The available evidence is predominantly retrospective, and prospective validation is needed before broad conclusions regarding oncologic outcomes can be drawn.
- 30 November 2021
- Published by Springer Nature
- p. 469-477
Crossed Cerebellar Diaschisis
- Open Access
- 13 August 2020
- Published by Springer Nature in Cureus
- Vol. 12 (8)
Incidental PET/CT Findings of Suspected COVID-19 in a Region of High Prevalence
We describe a case of suspected COVID-19 pneumonia in a 61-year-old male with known primary central nervous system diffuse large B-cell lymphoma (DLBCL) who underwent restaging PET/CT during the initial peak of infection of COVID-19 pneumonia within the New York region. At the time of his routine PET-CT to assess for disease progression, typical CT imaging features of COVID-19 pneumonia were identified. Upon further investigation, the patient was asymptomatic, and his infection status remained unknown. He was subsequently lost to follow-up with his COVID-19 status pending.
- 13 August 2020
- Published by Springer Nature in Cureus
- Vol. 12 (8)
Open AccessIncidental PET/CT Findings of Suspected COVID-19 in a Region of High Prevalence
We describe a case of suspected COVID-19 pneumonia in a 61-year-old male with known primary central nervous system diffuse large B-cell lymphoma (DLBCL) who underwent restaging PET/CT during the initial peak of infection of COVID-19 pneumonia within the New York region. At the time of his routine PET-CT to assess for disease progression, typical CT imaging features of COVID-19 pneumonia were identified. Upon further investigation, the patient was asymptomatic, and his infection status remained unknown. He was subsequently lost to follow-up with his COVID-19 status pending.
- Open Access
- 17 May 2020
- Published by Morressier GmbH
Metabolic PET/MRI in Primary Progressive Aphasia and FTD Subtypes: Reassessment of Expected FDG Uptake Patterns
PURPOSE: Clinical evaluation of patients with frontotemporal lobar degeneration (FTLD) and suspected PPA is clinically challenging given that common cognitive assessments rely extensively on language. Since asymmetry in imaging biomarkers is often described as central finding in FTLD patients, this study evaluated FDG uptake patterns in patients meeting criteria for FTLD with
- 17 May 2020
- Published by Morressier GmbH
Open AccessMetabolic PET/MRI in Primary Progressive Aphasia and FTD Subtypes: Reassessment of Expected FDG Uptake Patterns
PURPOSE: Clinical evaluation of patients with frontotemporal lobar degeneration (FTLD) and suspected PPA is clinically challenging given that common cognitive assessments rely extensively on language. Since asymmetry in imaging biomarkers is often described as central finding in FTLD patients, this study evaluated FDG uptake patterns in patients meeting criteria for FTLD with
- Open Access
- 17 May 2020
- Published by Morressier GmbH
Plaques and Tangles: PET-MRI Study of World Trade Center Cognitively Impaired Responders
PURPOSE: Recent evidence has demonstrated a high risk neurocognitive (including cognitive impairment, CI) and neurobehavioral symptoms (including post-traumatic stress disorder, PTSD) amongst responders to the 9/11/2001 attacks at the World Trade Center (WTC). We examined PET/MRI biomarker data in WTC responders with neurocognitive and neurobehavioral symptoms to identify
- 17 May 2020
- Published by Morressier GmbH
Open AccessPlaques and Tangles: PET-MRI Study of World Trade Center Cognitively Impaired Responders
PURPOSE: Recent evidence has demonstrated a high risk neurocognitive (including cognitive impairment, CI) and neurobehavioral symptoms (including post-traumatic stress disorder, PTSD) amongst responders to the 9/11/2001 attacks at the World Trade Center (WTC). We examined PET/MRI biomarker data in WTC responders with neurocognitive and neurobehavioral symptoms to identify